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Background
Protoporphyrin IX (PPIX) was shown to strongly activate in vitro the soluble guanylate cyclase enzyme (sGC), which makes it an interesting drug candidate for treatment of hypertension [1, 2] . In order to overcome the problem of PPIX poor bioavailability (especially in the case of oral administration), we decided to exploit the specific uptake pathway of vitamin B 12 , which was frequently used for delivering biologically active substances from the digestive system into the body cells. To this end, we embarked on the synthesis of a series of hybrid molecules, containing PPIX and vitamin B 12 moieties, linked via chains of different length and chemical character [3] .
Methods and results
Our synthetic approach is based on the synthesis of linking molecules containing a primary -NH 2 group and -N 3 or alkyne group at the other end. Amine functionality allows us to connect these linkers to vitamin B 12 , and to PPIX, finally, the union of the two parts is possible using Cu-catalyzed azide alkyne cycloaddition (the "click reaction") [4] .
